Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06402370

Amyloid PET in Patients With Mild Cognitive Impairment and Early Dementia

Sponsor: University Hospital, Ghent

View on ClinicalTrials.gov

Summary

The National Institute on Aging together with the Alzheimer's Association (NIA-AA) recently proposed the ATN classification which is based upon the pathological processes present in Alzheimer's disease (amyloid, tau and neurodegeneration). The amyloid and tau status can be defined using cerebrospinal fluid analysis but also non-invasively using an amyloid or tau PET scan. The N status can be defined using an \[18F\]-FDG PET scan which is in Belgium part of standard of care. Recently, it has been demonstrated, using different amyloid PET tracers, that early-frame amyloid scans can be a surrogate for \[18F\]-FDG PET scan.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2024-05-08

Completion Date

2026-05

Last Updated

2024-05-20

Healthy Volunteers

Not specified

Conditions

Interventions

DIAGNOSTIC_TEST

PET scan

\[18F\]Vizamyl

Locations (1)

Van Weehaeghe D

Ghent, Belgium